Science Explorer Interactive view Map
Company · Vienna · Austria

Boehringer Ingelheim (Austria)

In research, Boehringer Ingelheim (Austria) stands highest in Life Sciences (#4,537 of 14,347 worldwide), Molecular Biology (#2,523 of 4,961 worldwide) and Biochemistry, Genetics and Molecular Biology (#4,174 of 7,814 worldwide), over all time. Relative to its size it is most specialised in Molecular Biology and Biochemistry, Genetics and Molecular Biology — Molecular Biology is 11.6× its share of world research.

boehringer-ingelheim.at/enROR OpenAlex
World rank, 2022–2025
#10,431
of 28,054 · #10,513 all time
Rank in Austria
#55
of 168
Research works
437
▲ 103% vs 2013–17
Citations
21k
48.5 per fractional work
Top-10% rate
23.1%
record average 16.5%
Open access
45%
world 28%

What is Boehringer Ingelheim (Austria) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #4,537 of 14,347 27.4%233
Molecular BiologySubfield #2,523 of 4,961 28.9%134
Biochemistry, Genetics and Molecular BiologyField #4,174 of 7,814 27.7%188
MedicineField #10,506 of 17,978 24.5%147
Health SciencesDomain #13,597 of 20,462 24.2%151

Each strip is that field’s whole ranked pool, with the notch where Boehringer Ingelheim (Austria) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Boehringer Ingelheim (Austria) specialise in?

Where its research is concentrated relative to its size: Molecular Biology takes 11.6× the share of its output that it takes of world research.

  1. Molecular BiologySubfield · 29.9 works12×
  2. Biochemistry, Genetics and Molecular BiologyField · 38.6 works8.4×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.14× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 8.45× its world share, 39 worksBiochemistry, Geneti…Immunology and Microbiology: 5.62× its world share, 5 worksImmunology and Micro…Neuroscience: 0.14× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.82× its world share, 1 worksPharmacology, Toxico…Chemistry: 3.97× its world share, 5 worksChemistryComputer Science: 0.24× its world share, 2 worksComputer ScienceEngineering: 0.17× its world share, 2 worksEngineeringEnvironmental Science: 0.29× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.64× its world share, 2 worksMaterials ScienceMathematics: 0.33× its world share, 0 worksMathematicsPhysics and Astronomy: 0.18× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.07× its world share, 0 worksHealth ProfessionsMedicine: 1.63× its world share, 27 worksMedicineNursing: 0.11× its world share, 0 worksNursingVeterinary: 0.96× its world share, 0 worksVeterinaryArts and Humanities: 0.04× its world share, 0 worksArts and HumanitiesDecision Sciences: 0.10× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.35× its world share, 1 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.4×. Every wedge is a field page.

Who are the top researchers at Boehringer Ingelheim (Austria)?

Ranked on the composite score, Flavio Solca, W. Kobinger and Wolfgang Sommergruber lead among researchers whose main affiliation is Boehringer Ingelheim (Austria).

  1. 1 Flavio Solca Austria · #257,505 worldwide 184 citations · 35 works
  2. 2 W. Kobinger Austria · #463,543 worldwide 73 citations · 22 works
  3. 3 Wolfgang Sommergruber Austria · #598,464 worldwide 40 citations · 16 works
  4. 4 Günther R. Adolf Austria · #625,306 worldwide 32 citations · 18 works
  5. 5 Norbert Kraut Austria · #1,093,593 worldwide 73 citations · 33 works
  6. 6 Frank Hilberg Austria · #1,105,435 worldwide 45 citations · 19 works
  7. 7 A. Cseh Austria · #1,224,770 worldwide 37 citations · 18 works
  8. 8 Harald Weinstabl Austria · #1,305,293 worldwide 34 citations · 26 works
  9. 9 Marco H. Hofmann Austria · #1,395,694 worldwide 48 citations · 22 works
  10. 10 Darryl B. McConnell Austria · #1,486,753 worldwide 25 citations · 18 works
All ranked researchers at Boehringer Ingelheim (Austria)

Which keywords describe research at Boehringer Ingelheim (Austria)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Therapy, Glycosylation, Transcriptional Regulation, Cancer, Tumor Microenvironment, Monoclonal Antibody, Monoclonal Antibodies and Therapeutic Antibodies.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Therapy8▲ 17×13 topics
  2. Glycosylation6▲ 69×3 topics
  3. Cancer6▲ 5.5×17 topics
  4. Transcriptional Regulation6▲ 45×6 topics
  5. Tumor Microenvironment5▲ 14×5 topics
  6. Monoclonal Antibody5▲ 116×2 topics
  7. Monoclonal Antibodies5▲ 61×3 topics
  8. Chemotherapy4▲ 7.4×11 topics
  9. Therapeutic Antibodies4▲ 76×2 topics
  10. Immunotherapy4▲ 6.7×10 topics
  11. BET Bromodomains4▲ 158×1 topic
  12. PROTACs4▲ 158×1 topic
  13. Cell Culture4▲ 37×2 topics
  14. Mammalian Cells4▲ 168×1 topic
  15. Recombinant Protein4▲ 168×1 topic
  16. Cancer Immunotherapy3▲ 24×3 topics
  17. Gene Therapy3▲ 20×4 topics
  18. Angiogenesis3▲ 11×5 topics
  19. PET Imaging3▲ 21×4 topics
  20. Drug Discovery3▲ 15×5 topics
  21. Breast Cancer3▲ 14×5 topics
  22. Targeted Therapy3▲ 15×4 topics
  23. Antibody Engineering3▲ 58×1 topic
  24. Fc Receptors3▲ 58×1 topic
  25. Immunity3▲ 7.5×5 topics
  26. Stromal Cells3▲ 38×2 topics
  27. Fibroblast Activation Protein2▲ 66×1 topic
  28. Immunosuppression2▲ 32×1 topic
  29. Tumor Regression2▲ 24×2 topics
  30. Genome Engineering2▲ 38×1 topic
  31. RNA-Guided2▲ 38×1 topic
  32. Apoptosis2▲ 7.8×7 topics
  33. Biopharmaceuticals2▲ 46×3 topics
  34. Immunogenicity2▲ 53×2 topics
  35. Mutation2▲ 12×4 topics
  36. Recombinant Proteins2▲ 72×2 topics
  37. Oncogenic Mutations2▲ 85×2 topics
  38. Proteasome Inhibitors2▲ 30×2 topics
  39. Protein Aggregation2▲ 41×1 topic
  40. Stability2▲ 9.4×1 topic

Which research topics does Boehringer Ingelheim (Austria) publish most on?

By volume in 2022–2025: Protein Degradation and Inhibitors, Viral Infectious Diseases and Gene Expression in Insects, Monoclonal and Polyclonal Antibodies Research and Peptidase Inhibition and Analysis.

Protein Degradation and Inhibitors: 4 fractional worksViral Infectious Diseases and Gene Expression in Insects: 4 fractional worksMonoclonal and Polyclona…3Monoclonal and Polyclonal Antibodies Research: 3 fractional worksPeptidase Inhibition and…2Peptidase Inhibition and Analysis: 2 fractional worksCRISPR and Genetic Engineering: 2 fractional worksHER2/EGFR in Cancer Research: 2 fractional worksProtein purification and…2Protein purification and stability: 2 fractional worksVirus-based gene therapy research: 2 fractional worksCancer Immunotherapy and Biomarkers: 2 fractional worksClick Chemistry and Applications: 1 fractional works
Molecular BiologyRadiology, Nuclear Medicine and ImagingOncologyGenetics1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein Degradation and Inhibitors Molecular Biology 4 works
  2. 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 4 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
  4. 4 Peptidase Inhibition and Analysis Oncology 2 works
  5. 5 CRISPR and Genetic Engineering Molecular Biology 2 works
  6. 6 HER2/EGFR in Cancer Research Oncology 2 works
  7. 7 Protein purification and stability Molecular Biology 2 works
  8. 8 Virus-based gene therapy research Genetics 2 works
  9. 9 Cancer Immunotherapy and Biomarkers Oncology 2 works
  10. 10 Click Chemistry and Applications Organic Chemistry 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.6%not open55.4%

World: 28% of research is openly available.

with international co-authors48.6%domestic only51.4%

World: 19% is written across borders.

How has Boehringer Ingelheim (Austria)'s research output changed?

Output in 2018–2022 was 103% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Vienna

All research institutions in Vienna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.